These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 19338555)

  • 1. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
    Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
    BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
    Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
    J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival.
    Yan TD; King J; Sjarif A; Glenn D; Steinke K; Morris DL
    Ann Surg Oncol; 2006 Nov; 13(11):1529-37. PubMed ID: 17009153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma.
    Yan TD; King J; Sjarif A; Glenn D; Steinke K; Al-Kindy A; Morris DL
    Ann Surg Oncol; 2007 May; 14(5):1718-26. PubMed ID: 17285398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases.
    Li X; Wang J; Li W; Huang Z; Fan W; Chen Y; Shen L; Pan T; Wu P; Zhao M
    Int J Hyperthermia; 2012; 28(8):721-8. PubMed ID: 23153217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
    Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
    Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local progression after radiofrequency ablation for pulmonary metastases.
    von Meyenfeldt EM; Prevoo W; Peyrot D; Lai A Fat N; Burgers SJ; Wouters MW; Klomp HM
    Cancer; 2011 Aug; 117(16):3781-7. PubMed ID: 21319158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
    Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.